A Case Study of Chimeric Antigen Receptor T Cell Function: Donor Therapeutic Differences in Activity and Modulation with Verteporfin

SIMPLE SUMMARY: The loss of tumor antigens prevents the immune system from recognizing and destroying cancer cells. Immune cells can remove these antigens and express them on their surface. Other immune cells becoming confused, kill the anti-tumor immune cells. By blocking this process using a drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Jiyong, Fang, Dexing, Gumin, Joy, Najem, Hinda, Sooreshjani, Moloud, Song, Renduo, Sabbagh, Aria, Kong, Ling-Yuan, Duffy, Joseph, Balyasnikova, Irina V., Pollack, Seth M., Puduvalli, Vinay K., Heimberger, Amy B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953964/
https://www.ncbi.nlm.nih.gov/pubmed/36831427
http://dx.doi.org/10.3390/cancers15041085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953964/
https://www.ncbi.nlm.nih.gov/pubmed/36831427
http://dx.doi.org/10.3390/cancers15041085

Ejemplares similares